M&G PLC Regeneron Pharmaceuticals, Inc. Transaction History
M&G PLC
- $16.6 Billion
- Q2 2025
A detailed history of M&G PLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, M&G PLC holds 13,575 shares of REGN stock, worth $7.65 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
13,575
Previous 13,573
0.01%
Holding current value
$7.65 Million
Previous $8.61 Million
17.22%
% of portfolio
0.04%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding REGN
# of Institutions
1,417Shares Held
88.7MCall Options Held
1.98MPut Options Held
1.75M-
Vanguard Group Inc Valley Forge, PA9.42MShares$5.31 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.76 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.19 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.72 Billion0.1% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.16 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $60.4B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...